High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY
Volume 58, Issue 5, Pages 481-493
Publisher
Springer Science and Business Media LLC
Online
2023-03-27
DOI
10.1007/s00535-023-01970-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Histological assessment based on liver biopsy: the value and challenges in NASH drug development
- (2022) Xiao-fei Tong et al. ACTA PHARMACOLOGICA SINICA
- End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB
- (2022) Da Huang et al. JOURNAL OF HEPATOLOGY
- Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B
- (2022) Dong Ji et al. JOURNAL OF HEPATOLOGY
- Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma
- (2021) Camille Péneau et al. GUT
- Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B
- (2021) Dong Ji et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Residual HBV DNA and pgRNA viraemia is associated with hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy
- (2021) Lung-Yi Mak et al. JOURNAL OF GASTROENTEROLOGY
- Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management
- (2021) Alicia Vachon et al. Viruses-Basel
- Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
- (2021) Isabel Graupera et al. Clinical Gastroenterology and Hepatology
- Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients with Chronic Hepatitis B Treated with Entecavir: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial
- (2020) Guanghua Rong et al. JOURNAL OF INFECTIOUS DISEASES
- Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients
- (2020) Lilian Yan Liang et al. JOURNAL OF GASTROENTEROLOGY
- Liver biopsy reliability in clinical trials: Thoughts from a liver pathologist
- (2020) Elizabeth Matthews Brunt JOURNAL OF HEPATOLOGY
- Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues
- (2019) Tetsuya Hosaka et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load
- (2019) Tai-Chung Tseng et al. GASTROENTEROLOGY
- On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
- (2019) Xiu-Juan Chang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Genotypes and Hot Spot Mutations of Hepatitis B Virus in Northwest Chinese Population and Its Correlation with Diseases Progression
- (2019) Wei Wang et al. Biomed Research International
- Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement
- (2018) T. Karlas et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients
- (2018) Barbara Testoni et al. JOURNAL OF HEPATOLOGY
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis
- (2017) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients
- (2016) W. Ray Kim et al. JOURNAL OF HEPATOLOGY
- HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics
- (2016) Toshifumi Tada et al. JOURNAL OF HEPATOLOGY
- Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
- (2014) Tai-Chung Tseng et al. GUT
- Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial
- (2014) Jianhui Qu et al. Trials
- Long-term therapy for chronic hepatitis B: Hepatitis B virus DNA suppression leading to cirrhosis reversal
- (2013) Patrick Marcellin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients
- (2013) Michelle Martinot-Peignoux et al. JOURNAL OF HEPATOLOGY
- Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection
- (2012) C-M Chu et al. BRITISH JOURNAL OF CANCER
- Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads
- (2012) Tai-Chung Tseng et al. HEPATOLOGY
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- (2012) Patrick Marcellin et al. LANCET
- High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis B
- (2012) Wai-Kay Seto et al. PLoS One
- Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure
- (2010) Zhihui Xu et al. JOURNAL OF GASTROENTEROLOGY
- Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B
- (2010) Catherine M. N. Croagh et al. LIVER INTERNATIONAL
- Liver biopsy
- (2008) Don C. Rockey et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now